Related Experiment Videos

Medical marijuana for the treatment of vismodegib-related muscle spasm

Joyce T Yuan¹, Tiffany L Tello¹, Carter Hultman²

¹Department of Dermatology, University of California, San Francisco, San Francisco, California.

JAAD Case Reports

|September 22, 2017

Abstract

No abstract available in PubMed .

Keywords:

BCC, basal cell carcinoma CBD, cannabidiol FDA, US Food and Drug Administration MM, medical marijuana THC, tetrahydrocannabinol basal cell carcinoma mS, multiple sclerosis medical marijuana muscle cramps vismodegib

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

US-based Delphi Consensus Study on Adjuvant Radiation Therapy (ART) in Node-Negative Cutaneous Squamous Cell Carcinoma (CSCC).

International journal of radiation oncology, biology, physics·2026

A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.

Journal of the National Cancer Institute·2026

Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma.

Journal of the American Academy of Dermatology·2026

Phase II Trial of First-line Axitinib plus Nivolumab in Patients with Advanced Mucosal Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Adjuvant radiation for major salivary gland adenoid cystic carcinoma in the modern era: updated patterns of care and survival from the National Cancer Database (2004-2021).

Oral oncology·2026

A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma.

Haematologica·2026

See all related articles